Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Two-year Follow-up to High-intensity Multi-component Agility Intervention That Improves Clinical and Motor Symptoms of Parkinson's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03193489
Recruitment Status : Unknown
Verified June 2017 by Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital.
Recruitment status was:  Active, not recruiting
First Posted : June 20, 2017
Last Update Posted : June 20, 2017
Sponsor:
Collaborator:
University Medical Center Groningen
Information provided by (Responsible Party):
Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital

Brief Summary:

Individualization of exercise is recommended but rarely performed in patients with Parkinson's disease (PD).

Unusually High Intensity and Individual Sensor Motor with Visuomotor Mobility Trainer The clinical symptoms, mobility and posture of PD patients. After 3 weeks of intensive treatment, treated patients and the control group were subjected to a two-year observation.

Objectives: The effect of the unusually highly intense and strictly individualized sensomotor and visuomotor agility program was determined for the clinical symptoms, mobility and stability of non-demented PD patients with a two-year follow-up. Detection and comparison of results of patients undergoing biphasic maintenance with the results of intensively treated patients and the control group.

Patients were recalled every 3 months after the first intensive examination and one year after a one-year control. The results of the active group were continuously compared with the results of the passive and control groups, thus determining the effectiveness of our treatment and the deterioration of the other groups in life-quality.

The treated groups will be divided into two. One Parkinson's group takes part in a treadmill treatment that takes place 3 times a week for 2 years. The other group does not undergo a special series of exercises after 3 weeks of intensive therapy.

Main outcome measures: Movement disorder Society Unified Parkinson Disease Rating Scale, Motor Experiences of Daily Living, a measure sensitive to changes in a broad spectrum of PD symptoms.

In group time, repeated measurements of variance analysis were compared to MDS-UPDRS M-EDL, Beck Depression Score, PDQ-39, EQ5D VAS, Schwab & England Scale for Parkinson's Disease. The TUG test and 12 static posturographic measurements are compared and compared to the healthy group as a standard.

An at-limit and individualized sensorimotor and visuomotor agility exercise program vs. standard care, will improve non-demeted, stage 2-3 PD patient's clinical symptoms, mobility, and postural stability by functionally meaningful margins. As a long-term solution, a follow-up treatment can slow down the progression of clinical symtoms.


Condition or disease Intervention/treatment Phase
Follow up Parkinson Disease Rehabilitation Other: Follow-up Other: Post-treatment control Other: Control Parkinson group Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A High-intensity Multi-component Agility Intervention in Parkinson's Patients: Two-year Follow-up
Actual Study Start Date : May 11, 2015
Actual Primary Completion Date : May 31, 2017
Estimated Study Completion Date : June 30, 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Exercise therapy
Parkinson's group takes part in a treadmill treatment that takes place 3 times a week for 2 years.
Other: Follow-up
Other: Post-treatment control
After 3 weeks of intensive treatment, no special exercises are performed as a control.

Other: Control Parkinson group
No treatment.




Primary Outcome Measures :
  1. Quality of life [ Time Frame: Follow-up 2 years ]
    Questionnaire

  2. posturography [ Time Frame: Follow-up 2 years ]
    body sway, Objective measurement of holding instability

  3. Timed up and Go test [ Time Frame: Follow-up 2 years ]
    Measuring the speed of walking



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Parkinson's disease
  • Hoenh Yahr scale of 2-3
  • Instability problem

Exclusion Criteria:

  • Severe heart problems
  • Severe demeanor
  • Alcoholism
  • Drug problems

Additional Information:
Layout table for additonal information
Responsible Party: Tollár József, Principal investigator, Somogy Megyei Kaposi Mór Teaching Hospital
ClinicalTrials.gov Identifier: NCT03193489     History of Changes
Other Study ID Numbers: IKEB0013/2015
First Posted: June 20, 2017    Key Record Dates
Last Update Posted: June 20, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Tollár József, Somogy Megyei Kaposi Mór Teaching Hospital:
Balance
Posturograpy
quality of life

Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases